Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1979-04-05
1980-09-23
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31195
Patent
active
042243432
ABSTRACT:
The level of prolactin in blood serum is reduced by administering tyrosine to a human. The tyrosine can be administered alone, or concomitantly with a drug which tends to increase blood serum prolactin levels.
REFERENCES:
Chem. Abstr., 79-87422s (1973), Goldstein.
Chem. Abstr., 85-140130c (1976), Sedvall.
Cook Paul J.
Friedman Stanley J.
Massachusetts Institute of Technology
Smith, Jr. Arthur A.
LandOfFree
Process and composition for decreasing blood serum prolactin lev does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process and composition for decreasing blood serum prolactin lev, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process and composition for decreasing blood serum prolactin lev will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-644917